Verwandte Artikel zu Molecular Histopathology and Tissue Biomarkers in Drug...
Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development (Methods in Pharmacology and Toxicology) - Hardcover
Zu dieser ISBN ist aktuell kein Angebot verfügbar.
Alle Exemplare der Ausgabe mit dieser ISBN anzeigen:
<P><I>MOLECULAR HISTOPATHOLOGY AND TISSUE BIOMARKERS IN DRUG AND DIAGNOSTIC DEVELOPMENT</I> GATHERS DIVERSE EXPERTS TO PRESENT STATE OF THE ART GUIDANCE AND APPLICATION OF HISTOPATHOLOGY IN DRUG DEVELOPMENT SETTINGS RANGING FROM DISCOVERY RESEARCH TO HUMAN CLINICAL TRIALS. WHILE MANY CURRENT APPLICATIONS OF QUANTITATIVE HISTOLOGY AND MOLECULAR PATHOLOGY IN THE BIOPHARMACEUTICAL INDUSTRY ARE FOCUSED ON ONCOLOGY, THIS VOLUME IN ADDITION EXPLORES NON-ONCOLOGIC DISEASE AREAS INCLUDING NONALCOHOLIC STEATOHEPATITIS, ARTHRITIS, CELIAC DISEASE, MYELOPROLIFERATIVE DISORDERS, NEUROLOGY, AND WOUND HEALING. THE AUTHORS WRITE FROM YEARS OF EXPERIENCE IN DIAGNOSTIC PRACTICE AND PHARMACEUTICAL DRUG DEVELOPMENT, AIMING TO EDUCATE PHARMACEUTICAL AND ACADEMIC SCIENTISTS HOW TO BEST USE TISSUE TO DIAGNOSE DISEASE AND IMPROVE THE PROCESS OF DRUG DEVELOPMENT. AS PART OF THE <I>METHODS IN PHARMACOLOGY AND TOXICOLOGY</I> SERIES, THIS VOLUME IS DESIGNED TO PROVIDE WISDOM AND EXAMPLES THAT OTHERS CAN FOLLOW AND APPLY AS PART OF DRUG DEVELOPMENT.</P><P>COMPREHENSIVE AND PRACTICAL, <I>MOLECULAR HISTOPATHOLOGY AND TISSUE BIOMARKERS IN DRUG AND DIAGNOSTIC DEVELOPMENT</I> WILL INFORM AND ENLIGHTEN BOTH TISSUE-FOCUSED AND NON-TISSUE-FOCUSED DRUG DEVELOPMENT PROFESSIONALS ABOUT BETTER USE AND INTERPRETATION OF THE MULTIDIMENSIONAL DATA CONTAINED IN A TISSUE BIOPSY.</P>
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Reseña del editor:
Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development gathers diverse experts to present state of the art guidance and application of histopathology in drug development settings ranging from discovery research to human clinical trials. While many current applications of quantitative histology and molecular pathology in the biopharmaceutical industry are focused on oncology, this volume in addition explores non-oncologic disease areas including nonalcoholic steatohepatitis, arthritis, celiac disease, myeloproliferative disorders, neurology, and wound healing. The authors write from years of experience in diagnostic practice and pharmaceutical drug development, aiming to educate pharmaceutical and academic scientists how to best use tissue to diagnose disease and improve the process of drug development. As part of the Methods in Pharmacology and Toxicology series, this volume is designed to provide wisdom and examples that others can follow and apply as part of drug development.
Comprehensive and practical, Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development will inform and enlighten both tissue-focused and non-tissue-focused drug development professionals about better use and interpretation of the multidimensional data contained in a tissue biopsy.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
- VerlagHumana
- Erscheinungsdatum2015
- ISBN 10 1493926802
- ISBN 13 9781493926800
- EinbandTapa dura
- Anzahl der Seiten375
- HerausgeberPotts Steven J., Eberhard David A., Wharton Jr. Keith A.
Neu kaufen
Mehr zu diesem Angebot erfahren
EUR 111,07
Versand:
EUR 32,99
Von Deutschland nach USA
Beste Suchergebnisse beim ZVAB
Foto des Verkäufers
Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development
Verlag:
Springer Nature Singapore
(2015)
ISBN 10: 1493926802
ISBN 13: 9781493926800
Neu
Hardcover
Anzahl: 2
Anbieter:
Bewertung
Buchbeschreibung Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development gathers diverse experts to present state of the art guidance and application of histopathology in drug development settings ranging from discovery research to human clinical trials. While many current applications of quantitative histology and molecular pathology in the biopharmaceutical industry are focused on oncology, this volume in addition explores non-oncologic disease areas including nonalcoholic steatohepatitis, arthritis, celiac disease, myeloproliferative disorders, neurology, and wound healing. The authors write from years of experience in diagnostic practice and pharmaceutical drug development, aiming to educate pharmaceutical and academic scientists how to best use tissue to diagnose disease and improve the process of drug development. As part of the Methods in Pharmacology and Toxicology series, this volume is designed to provide wisdom and examples that others can follow and apply as part of drug development.Comprehensive and practical, Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development will inform and enlighten both tissue-focused and non-tissue-focused drug development professionals about better use and interpretation of the multidimensional data contained in a tissue biopsy. Artikel-Nr. 9781493926800
Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren
Neu kaufen
EUR 111,07
Währung umrechnen